Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Progress in the treatment of acute myeloid leukemia.
Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Ravandi F, et al. Among authors: agura ed. Cancer. 2007 Nov 1;110(9):1900-10. doi: 10.1002/cncr.23000. Cancer. 2007. PMID: 17786921 Free article. Review.
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT, Bruno B, Petersen FB, Maris MB, Agura E, Yeager A, Bethge W, Sahebi F, Appelbaum FR, Maloney DG, Sandmaier BM. Gyurkocza B, et al. J Clin Oncol. 2010 Jun 10;28(17):2859-67. doi: 10.1200/JCO.2009.27.1460. Epub 2010 May 3. J Clin Oncol. 2010. PMID: 20439626 Free PMC article.
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
Agura E, Cooper B, Holmes H, Vance E, Berryman RB, Maisel C, Li S, Saracino G, Tadic-Ovcina M, Fay J. Agura E, et al. Oncologist. 2011;16(2):197-206. doi: 10.1634/theoncologist.2010-0220. Epub 2011 Jan 27. Oncologist. 2011. PMID: 21273514 Free PMC article. Clinical Trial.
Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Vaughn JE, Sorror ML, Storer BE, Chauncey TR, Pulsipher MA, Maziarz RT, Maris MB, Hari P, Laport GG, Franke GN, Agura ED, Langston AA, Rezvani AR, Storb R, Sandmaier BM, Maloney DG. Vaughn JE, et al. Among authors: agura ed. Cancer. 2015 Oct 15;121(20):3709-16. doi: 10.1002/cncr.29498. Epub 2015 Jul 24. Cancer. 2015. PMID: 26207349 Free PMC article.
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
Kim HT, Ahn KW, Hu ZH, Davids MS, Volpe VO, Antin JH, Sorror ML, Shadman M, Press O, Pidala J, Hogan W, Negrin R, Devine S, Uberti J, Agura E, Nash R, Mehta J, McGuirk J, Forman S, Langston A, Giralt SA, Perales MA, Battiwalla M, Hale GA, Gale RP, Marks DI, Hamadani M, Ganguly S, Bacher U, Lazarus H, Reshef R, Hildebrandt GC, Inamoto Y, Cahn JY, Solh M, Kharfan-Dabaja MA, Ghosh N, Saad A, Aljurf M, Schouten HC, Hill BT, Pawarode A, Kindwall-Keller T, Saba N, Copelan EA, Nathan S, Beitinjaneh A, Savani BN, Cerny J, Grunwald MR, Yared J, Wirk BM, Nishihori T, Chhabra S, Olsson RF, Bashey A, Gergis U, Popat U, Sobecks R, Alyea E, Saber W, Brown JR. Kim HT, et al. Clin Cancer Res. 2019 Aug 15;25(16):5143-5155. doi: 10.1158/1078-0432.CCR-18-3988. Epub 2019 Jun 28. Clin Cancer Res. 2019. PMID: 31253630 Free PMC article.
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
Sorror ML, Sandmaier BM, Storer BE, Franke GN, Laport GG, Chauncey TR, Agura E, Maziarz RT, Langston A, Hari P, Pulsipher MA, Bethge W, Sahebi F, Bruno B, Maris MB, Yeager A, Petersen FB, Vindeløv L, McSweeney PA, Hübel K, Mielcarek M, Georges GE, Niederwieser D, Blume KG, Maloney DG, Storb R. Sorror ML, et al. JAMA. 2011 Nov 2;306(17):1874-83. doi: 10.1001/jama.2011.1558. JAMA. 2011. PMID: 22045765 Free PMC article.
The use of ranitidine in bone marrow transplantation. A review of 223 cases.
Agura ED, Vila E, Petersen FB, Shields AF, Thomas ED. Agura ED, et al. Transplantation. 1988 Jul;46(1):53-6. doi: 10.1097/00007890-198807000-00008. Transplantation. 1988. PMID: 3293286 Review.
Allogeneic blood cell transplantation without posttransplant colony-stimulating factors in patients with hematopoietic neoplasm: a phase II study.
Rosenfeld C, Collins R, Piñeiro L, Agura E, Nemunaitis J. Rosenfeld C, et al. J Clin Oncol. 1996 Apr;14(4):1314-9. doi: 10.1200/JCO.1996.14.4.1314. J Clin Oncol. 1996. PMID: 8648389 Clinical Trial.
Modification of the Bu/Cy myeloablative regimen using daily parenteral busulfan: reduced toxicity without the need for pharmacokinetic monitoring.
Mamlouk K, Saracino G, Berryman RB, Fay JW, Pineiro LA, Vance EA, White M, Sandler I, Agura ED. Mamlouk K, et al. Among authors: agura ed. Bone Marrow Transplant. 2005 Apr;35(8):747-54. doi: 10.1038/sj.bmt.1704871. Bone Marrow Transplant. 2005. PMID: 15750611 Clinical Trial.
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Baron F, Maris MB, Storer BE, Sandmaier BM, Stuart MJ, McSweeney PA, Radich JP, Pulsipher MA, Agura ED, Chauncey TR, Maloney DG, Shizuru JA, Storb R. Baron F, et al. Among authors: agura ed. Biol Blood Marrow Transplant. 2005 Apr;11(4):272-9. doi: 10.1016/j.bbmt.2004.12.326. Biol Blood Marrow Transplant. 2005. PMID: 15812392
24 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page